[3] [4] According to the ancient Near East scholar Alberto R
Cheng, Jin-Pei
DSIP has been studied primarily via intravenous infusion in clinical research (12 mg per session), though subcutaneous injection is also used
The reduction in AUC after oral administration can result from numerous mechanisms including: pH or bacterial-mediated metabolism of the drug within the GI tract, incomplete drug absorption from the GI tract, metabolism within the GI epithelium (which contains CYP3A4), excretion back into the GI tract by P-glycoprotein in the GI epithelium, hepatic metabolism, or biliary excretion into the GI tract
The older we get, the more likely we are to suffer from lower levels of semorelin and growth hormone, as the aging process has slowed down the bodys production of the hormone
No form of GHK-Cu, BPC-157, or TB-500 is FDA-approved for human use